Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket

Published 27/02/2023, 12:45
© Reuters. Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.
  • ObsEva SA (NASDAQ: OBSV) rose 60.3% to $0.1331 in pre-market trading. ObsEva shares dropped over 50% on Friday after the company announced strategic reorganization to consolidate operations in Switzerland.
  • Monopar Therapeutics Inc. (NASDAQ: MNPR) rose 19.8% to $3.92 in pre-market trading.
  • Troika Media Group, Inc. (NASDAQ: TRKA) rose 16.4% to $0.3550 in pre-market trading after gaining over 17% on Friday.
  • Inpixon (NASDAQ: INPX) rose 13% to $1.30 in pre-market trading.
  • Seagen Inc. (NASDAQ: SGEN) rose 12.8% to $182.00 in pre-market trading. Pfizer is in early discussions to purchase Seagen in a deal likely valued at more than $30 billion, The Wall Street Journal reported late on Sunday.
  • Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 12.4% to $0.1910 in pre-market trading after gaining over 5% on Friday.
  • AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 10.7% to $1.86 in pre-market trading after gaining more than 10% on Friday.
  • Molekule Group, Inc. (NASDAQ: MKUL) rose 9% to $2.67 in pre-market trading after the company agreed to acquire Aura Smart Air Ltd, in an all-stock merger with a value of around $10 million.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) shares rose 7.8% to $1.65 in pre-market trading.
Losers
  • TEGNA Inc. (NYSE: TGNA) shares fell 24% to $16.61 in pre-market trading after the Federal Communications Commission announced plans to hold a hearing on Standard General's bid for Tegna.
  • Cyren Ltd. (NASDAQ: CYRN) fell 19.1% to $0.2750 in pre-market trading after surging around 62% on Friday. CYREN, last week, said it will be delisted from the Nasdaq.
  • Connexa Sports Technologies Inc. (NASDAQ: CNXA) fell 14% to $0.18 in pre-market after jumping more than 49% on Friday.
  • Ocean Biomedical, Inc. (NASDAQ: OCEA) shares dropped 13.9% to $8.60 in pre-market trading after dropping over 7% on Friday. Ocean Biomedical recently issued a press release celebrating the discovery of bispecific antibodies and immune checkpoint inibitors that kill glioblastoma cells and melanoma cells and block the metastasis of malignant melanoma cells to the lung by over 90%.
  • Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 7% to $1.07 in pre-market trading after gaining around 5% on Friday. Jounce Therapeutics and Redx recently announced a recommended business combination.
  • Taboola.com Ltd. (NASDAQ: TBLA) fell 7% to $3.07 in pre-market trading. Taboola.com shares dropped 19% on Friday after the company reported Q4 financial results.
  • SeqLL Inc. (NASDAQ: SQL) fell 6.5% to $0.71 in pre-market trading. SeqLL recently announced pricing of an $1.8 million registered direct offering.
  • Zenvia Inc. (NASDAQ: ZENV) fell 6% to $1.10 in pre-market trading. Zenvia recently launched the integration of its mass texting service solution, Zenvia Attraction, with ChatGPT (GPT-3) via API.
  • Protalix BioTherapeutics, Inc. (NYSE: PLX) shares fell 5% to $1.73 in pre-market trading after gaining 7% on Friday. Chiesi Global Rare Diseases and Protalix BioTherapeutics recently received CHMP opinion for pegunigalsidase alfa for treatment of Fabry disease.
  • Kosmos Energy Ltd. (NYSE: KOS) fell 5% to $7.18 in pre-market trading after posting results for its fourth quarter. The company said it sees Q1 capex of $200 million to $225 million.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.